Luca Mastracci
Università degli Studi di Genova
H-index: 44
Europe-Italy
Top articles of Luca Mastracci
Gastric carcinoma in autoimmune gastritis: a histopathologic and molecular study
Modern Pathology
2024/4/6
Very early onset inflammatory bowel diseases: Is it the time to share and define a histopathological reporting scheme?
Digestive and Liver Disease
2024/2/12
Luca Mastracci
H-Index: 28
Federica Grillo
H-Index: 25
Expression of epidermal growth factor receptor (EGFR) in systemic sclerosis patients (SSc) and gastro-oesophageal reflux disease (GORD)
2021/5/20
IDH1‐mutated Crohn's disease‐associated small bowel adenocarcinomas: Distinctive pathological features and association with MGMT methylation and serrated …
Histopathology
2024/2
Application of a pattern‐based approach to histological diagnosis in very early onset IBD (VEO‐IBD) in a multicentric cohort of children with emphasis on monogenic disease with …
Histopathology
2024/2
Valentina Angerilli
H-Index: 1
Rita Alaggio
H-Index: 29
Luca Mastracci
H-Index: 28
Federica Grillo
H-Index: 25
miRNA–221 and miRNA–483–3p Dysregulation in Esophageal Adenocarcinoma
Cancers
2024/1/30
Correction to: Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reporting
Virchows Archiv: an international journal of pathology
2024/1/17
Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center
European Journal of Cancer Prevention
2024/1/9
Alberto Puccini
H-Index: 15
Valentino Martelli
H-Index: 3
Luca Mastracci
H-Index: 28
Federica Grillo
H-Index: 25
BRAFV600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer
Histopathology
2024/1/3
Xanthophyll-Rich Extract of Phaeodactylum tricornutum Bohlin as New Photoprotective Cosmeceutical Agent: Safety and Efficacy Assessment on In Vitro …
Molecules
2023/5/19
Bruno Burlando
H-Index: 26
Laura Cornara
H-Index: 21
Federica Grillo
H-Index: 25
Luca Mastracci
H-Index: 28
The day-to-day practice of MMR and MSI assessment in colorectal adenocarcinoma: what we know and what we still need to explore
2023/5/15
Colorectal adenosquamous carcinoma: genomic profiling of a rare histotype of colorectal cancer
Virchows Archiv
2023/5
Valentina Angerilli
H-Index: 1
Giovanni Perrone
H-Index: 15
Federica Grillo
H-Index: 25
Luca Mastracci
H-Index: 28
Loss of primary cilia potentiates BRAF/MAPK pathway activation in rhabdoid colorectal carcinoma: a series of 21 cases showing ciliary rootlet CoiledCoil (CROCC) alterations
Genes
2023/4/27
A practical approach for PD-L1 evaluation in gastroesophageal cancer
2023/4
Valentina Angerilli
H-Index: 1
Irene Gullo
H-Index: 12
Chiara Rossi
H-Index: 3
Federica Grillo
H-Index: 25
Luca Mastracci
H-Index: 28
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells
Journal of Experimental & Clinical Cancer Research
2023/3/18
Francesco Reggiani
H-Index: 8
Luca Mastracci
H-Index: 28
Federica Grillo
H-Index: 25
Antonio Rosato
H-Index: 5
Counting mitoses in gastrointestinal stromal tumours (GISTs): Variable practices in the real-world setting and their clinical implications
Virchows Archiv
2023/3
Federica Grillo
H-Index: 25
Luca Mastracci
H-Index: 28
Dasatinib-induced Crohn’s-like colitis
Journal of Clinical Pathology
2023/3/1
Federica Grillo
H-Index: 25
Luca Mastracci
H-Index: 28
Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reporting
Virchows Archiv
2023/12/23
Correlations between Molecular Alterations, Histopathological Characteristics, and Poor Prognosis in Esophageal Adenocarcinoma
Cancers
2023/2/23
SB202190 predicts BRAF-activating mutations in primary colorectal cancer organoids via Erk1-2 modulation
Cells
2023/2/20
Luca Mastracci
H-Index: 28
Federica Grillo
H-Index: 25
